InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

Adaptive Biotechnologies Corp

ADPT Clue Score46
United States Fiscal year ends December CIK 0001478320 Results filed 4 Nov 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

36
Insider
Date
Role
Action
Shares
Price
Amount
Susan Bobulsky
6 Oct 2026
Chief Commercial Officer, MRD
Sold on a plan
6,444
$30.00
$193.32K
Susan Bobulsky
15 Sep 2026
Chief Commercial Officer, MRD
Sold on a plan
1,195
$27.00
$32.27K
Susan Bobulsky
10 Aug 2026
Chief Commercial Officer, MRD
Sold on a plan
3,000
$25.00
$75.00K
Susan Bobulsky
30 Jul 2026
Chief Commercial Officer, MRD
Sold on a plan
1,299
$24.00
$31.18K
Susan Bobulsky
16 Jul 2026
Chief Commercial Officer, MRD
Sold on a plan
5,000
$23.00
$115.00K
Harlan S Robins
2 Jul 2026
Chief Scientific Officer
Sold on a plan
146,889
$22.45
$3.30M
Harlan S Robins
2 Jul 2026
Chief Scientific Officer
Sold on a plan
239,351
$21.74
$5.20M
Susan Bobulsky
1 Jul 2026
Chief Commercial Officer, MRD
Sold on a plan
487
$22.00
$10.71K
Susan Bobulsky
25 Jun 2026
Chief Commercial Officer, MRD
Sold on a plan
5,000
$20.50
$102.50K
Harlan S Robins
16 Jun 2026
Chief Scientific Officer
Sold on a plan
6,160
$18.01
$110.94K
Harlan S Robins
15 Jun 2026
Chief Scientific Officer
Sold on a plan
100,000
$17.37
$1.74M
Susan Bobulsky
11 Jun 2026
Chief Commercial Officer, MRD
Sold on a plan
5,000
$19.00
$95.00K
Susan Bobulsky
4 Jun 2026
Chief Commercial Officer, MRD
Sold on a plan
11,000
$18.00
$198.00K
Chad M Robins
8 Apr 2026
CEO and Chairman
Sold on a plan
37,263
$15.19
$566.02K
Harlan S Robins
8 Apr 2026
Chief Scientific Officer
Sold on a plan
10,000
$14.85
$148.50K
Chad M Robins
6 Apr 2026
CEO and Chairman
Sold on a plan
83,332
$14.41
$1.20M
Francis Lo
11 Mar 2026
Chief People Officer
Sold on a plan
30,593
$14.08
$430.75K
Chad M Robins
3 Mar 2026
CEO and Chairman
Sold on a plan
2,380
$16.15
$38.44K
Chad M Robins
3 Mar 2026
CEO and Chairman
Sold on a plan
50,703
$15.49
$785.39K
Harlan S Robins
3 Mar 2026
Chief Scientific Officer
Sold on a plan
14,233
$16.52
$235.13K
Chad M Robins
2 Mar 2026
CEO and Chairman
Sold on a plan
289,024
$15.82
$4.57M
Harlan S Robins
2 Mar 2026
Chief Scientific Officer
Sold on a plan
10,000
$15.72
$157.20K
Chad M Robins
27 Feb 2026
CEO and Chairman
Sold on a plan
182,891
$15.99
$2.92M
Harlan S Robins
3 Feb 2026
Chief Scientific Officer
Sold on a plan
8,120
$19.00
$154.28K
Chad M Robins
2 Feb 2026
CEO and Chairman
Sold on a plan
124,998
$18.44
$2.30M
Harlan S Robins
2 Feb 2026
Chief Scientific Officer
Sold on a plan
34,668
$18.60
$644.82K
Harlan S Robins
6 Jan 2026
Chief Scientific Officer
Sold on a plan
10,000
$16.44
$164.40K
Chad M Robins
5 Jan 2026
CEO and Chairman
Sold on a plan
124,998
$15.59
$1.95M
Harlan S Robins
4 Dec 2025
Chief Scientific Officer
Sold on a plan
10,000
$16.61
$166.10K
Harlan S Robins
3 Dec 2025
Chief Scientific Officer
Sold on a plan
27,212
$18.61
$506.42K
Chad M Robins
1 Dec 2025
CEO and Chairman
Sold on a plan
124,998
$18.94
$2.37M
Chad M Robins
26 Nov 2025
CEO and Chairman
Sold on a plan
35,736
$19.68
$703.28K
Chad M Robins
12 Nov 2025
CEO and Chairman
Sold on a plan
1,867
$15.00
$28.01K
Chad M Robins
11 Nov 2025
CEO and Chairman
Sold on a plan
1,237
$14.57
$18.02K
Chad M Robins
10 Nov 2025
CEO and Chairman
Sold on a plan
86,161
$14.73
$1.27M
Harlan S Robins
10 Nov 2025
Chief Scientific Officer
Sold on a plan
10,000
$14.82
$148.20K
Show all 172 transactions →

What was left out

Form 4 filings counted 91
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 36
Sales straight out of an exercise 123
Sales at will 13
Transactions with no price 0
Shares from compensation/vesting 5,328,696
History held since 2 Jul 2019